Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 4—April 2019

Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type-1 Transmission

Alice R. Tang, Graham P. Taylor, and Divya DhasmanaComments to Author 
Author affiliations: Imperial College London, London, UK (A.R. Tang, G.P. Taylor); St. Mary’s Hospital, London (G.P. Taylor, D. Dhasmana)

Main Article


Characteristics of 10 case-patients infected with HTLV-1 who practice self-flagellation, United Kingdom*

Case-patient Age at diagnosis, y Country of birth or ethnicity HTLV-1 proviral load % Route of diagnosis HTLV-1 status of regular sexual partner Sharing of equipment Characteristic
A 34 Indian 0.8 Screening for IVF Negative Yes Blood donor in UK 9 y earlier, documented HTLV negative
B 40 Pakistan 0.7 Cord blood donor (partner) Positive Yes Hepatitis C virus co-infection now cured
C 47 Pakistan 0.8 Screening for IVF Negative Yes Multiple previous blood donations in Pakistan
D 25 Pakistan 0.79 UK blood donor No current partner Yes Previous blood donor in Pakistan
E 37 Pakistan 2.11 Cord blood donor (partner) Positive Yes None
F 31 UK, Indian 0.14 UK blood donor Negative Yes None
G 22 UK, Pakistani 0.4 UK blood donor Positive No Received sutures in Iraq; wife seroconverted and became pregnant
H 33 UK, Indian 2.69 UK blood donor Negative Yes None
I 37 Pakistan Undetectable UK blood donor Negative No Sample/cutoff ratio >80†
J 38 Iraq 0.001 UK blood donor Unknown Yes None

*All case-patients were male. HTLV-1, human T-cell lymphotropic virus type 1; IVF, in vitro fertilization.
†For an enzyme immunoassay assay.

Main Article

Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.